MOUSE INTERLEUKIN-12 (IL-12) P40 HOMODIMER - A POTENT IL-12 ANTAGONIST

Citation
S. Gillessen et al., MOUSE INTERLEUKIN-12 (IL-12) P40 HOMODIMER - A POTENT IL-12 ANTAGONIST, European Journal of Immunology, 25(1), 1995, pp. 200-206
Citations number
31
Categorie Soggetti
Immunology
ISSN journal
00142980
Volume
25
Issue
1
Year of publication
1995
Pages
200 - 206
Database
ISI
SICI code
0014-2980(1995)25:1<200:MI(PH->2.0.ZU;2-5
Abstract
Interleukin-12 (IL-12) is a cytokine that has regulatory effects on T and natural killer (NK) cells and is composed of two disulfide-bonded subunits, p40 and p35. It was recently reported that supernatants from cultures of mouse IL-12 (moIL-12) p40-transfected COS cells could inh ibit IL-12-dependent responses in vitro (Mattner, F., et al., Eur. J. Immunol. 1993. 23: 2202). We have further characterized the nature of the inhibitory substance. Purified mouse p40 produced in a baculovirus expression system was found to consist of two species: the p40 monome r and a disulfide-linked p40 dimer [(p40)(2)]. The (p40)(2) was 25- to 50-fold more active than the p40 monomer in causing specific, dose-de pendent inhibition of IL-12-induced mouse concanavalin A (Con A) blast proliferation and could also inhibit IL-12-induced interferon-gamma ( IFN-gamma) secretion by mouse splenocytes and IL-12-dependent activati on of mouse NK cells. Competitive binding studies on mouse Con A blast s showed that (p40)(2) was equally effective as moIL-12 in competing w ith I-125-labeled moIL-12 ([I-125]moIL-12) for binding to mouse Con A blasts. However, in contrast to moIL-12, mouse (p40)(2) displayed litt le ability to compete with I-125-labeled human IL-12 (huIL-12) for bin ding to high-affinity IL-12 receptors (IL-12R) on human phytohemagglut inin (PI-IA) blasts and caused little or no inhibition of huIL-12-indu ced human PHA blast proliferation. Nonetheless, mouse (p40)(2) was equ ally effective as moIL-12 in competing with [I-125]huIL-12 for binding to COS cells transfected with the human IL-12R beta subunit and expre ssing low-affinity IL-12 binding sites. These results suggest that (i) the majority of the structural determinants required for binding of I L-12 to its receptor are contained within the p40 subunit, but p35 is required for signaling, (ii) the p40 subunit of 11,-12 interacts with the beta subunit of IL-12R, and (iii) (p40)(2) may be a suitable IL-12 antagonist for studying the role of IL-12 in various immune responses in vice as well as in vitro. Further studies are required to determin e whether or not (p40)(2) is produced by normal lymphoid cells and is a physiologic regulator of IL-12 activity.